ALB and colorectal carcinoma: After adjusting the confounding covariates, TNM stage (HR = 3.31, HR = 2.06 − 5.30, P < 0.001), T stage (HR = 3.34, HR = 1.60‐6.93, P = 0.0013), LDH/ALB (HR = 2.80, 95% CI: 1.83-4.26, P < 0.001), and MON/ALB (HR = 2.57, 95% CI: 1.63-4.04, P < 0.001) were risk factors for unfavorable DFS in CRC patients (Figure 3(b)).